Edgewell Personal Care vs Haleon
EPC and HLN side by side, both in soap, detergents, and cleaning preparations; perfumes, cosmetics, and other toilet preparations. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EPC and HLN compare
Edgewell Personal Care grew revenue faster over the last twelve months (1.8% versus −1.8% for Haleon).
Haleon keeps more of each dollar of sales as profit, with a net margin of 15.1% compared with −2.6% at Edgewell Personal Care.
Edgewell Personal Care pays a dividend yielding 2.2%; Haleon does not pay one.
Haleon scores higher on the StockData Score (9 against 4 for Edgewell Personal Care), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EPC | HLN |
|---|---|---|
| Size and price | ||
| Market cap | $1.3B | – |
| Share price | $27.28 | $9.17 |
| Change, 1 year | 44.3% | −7.2% |
| Change, 5 years | −38.2% | – |
| Beta (5Y) | 0.67 | 0.17 |
| Employees | 6,700 | – |
| StockData Score | ||
| Total score | 4 | 9 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 4 (better) |
| Health score | 1 | 2 (better) |
| Dividend score | 1 (better) | 0 |
| Valuation | ||
| P/S | 0.6× | – |
| P/B | 0.9× | – |
| EV/EBITDA | 17.8× | – |
| FCF yield | −0.80% | – |
| Fair value | $18.83 | – |
| Margin of safety | −44.9% | – |
| Growth | ||
| Revenue growth (TTM) | 1.8% (better) | −1.8% |
| Revenue growth, 5Y average | −0.89% | 2.2% (better) |
| Net income growth (TTM) | −304% | 15.6% (better) |
| EPS growth (TTM) | −311% | 17.8% (better) |
| EPS growth, 5Y average | – | 8.3% |
| Profitability | ||
| Gross margin | 41.6% | 64.2% (better) |
| Operating margin | 2.1% | 21.9% (better) |
| Net margin | −2.6% | 15.1% (better) |
| FCF margin | −0.50% | 21.0% (better) |
| Return on equity | −3.4% | 10.2% (better) |
| Return on invested capital | 1.3% | 7.9% (better) |
| Financial health | ||
| Debt / equity | 0.85 | 0.50 (better) |
| Net debt / EBITDA | 7.30 | 2.68 (better) |
| Interest coverage | 0.6× | 7.1× (better) |
| Current ratio | 1.82 (better) | 0.69 |
| Altman Z-score | 1.53 | – |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.2% | – |
| Buyback yield | 1.3% | – |
| Shareholder yield | 3.5% | – |
| Ownership | ||
| Held by institutions | 117% | 6.7% |
| Held by insiders | 1.5% | 0.00% |
| Insider net buying, 12 months | $0 | – |
| Superinvestors holding | – | 2 |
| Short interest, % of float | 10.9% | – |
Go deeper
- EPC stock overview
- EPC income statement
- EPC valuation and score
- HLN stock overview
- HLN income statement
- HLN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.